how are pharmacies still compounding semaglutide title π¨ Important Update on Compounded GLP-1 Injectables π¨ The FDA has announced that the shortage is resolved, requiring all 503A to stop and dispensing injectable semaglutide by April What Is Compounded Semaglutide and
Description
No recurrence of angioedema was observed during the following 6 months of semaglutide therapy, and CSU symptoms remained minimal (UAS7 2) with 10 mg of rupatadine per week for 20 consecutive months
This was legal because the drug was technically in shortage

Common side effects during the first 24 weeks include mild nausea, reduced appetite, and occasional constipation as your body adjusts

As a 503A pharmacy, Red Rock legally requires a valid prescription from a licensed healthcare provider for every order

Beyond obtaining a thorough clinical history to assess risk factors, clinicians can use risk prediction equations, cardiac imaging, and biomarkers of myocyte injury or stress to stratify ASCVD

This framing supports the case for continued access to GLP-1 medications even after patients achieve their target weight, which relates to concerns about semaglutide withdrawal symptoms and weight regain after stopping treatment